CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, F.
Right arrow Articles by Ljungman, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, F.
Right arrow Articles by Ljungman, M.
Cell Growth & Differentiation Vol. 11, 239-246, May 2000
© 2000 American Association for Cancer Research


Articles

Role of p53 in Cell Cycle Regulation and Apoptosis following Exposure to Proteasome Inhibitors1

Feng Chen, Daniel Chang, Meidee Goh, Sergey A. Klibanov and Mats Ljungman2

Department of Radiation Oncology, Division of Cancer Biology, University of Michigan Comprehensive Cancer Center [F. C., D. C., S. A. K., M. L.] and Section of Urology [M. G.], Program in Cellular and Molecular Biology [M. L.], University of Michigan Medical School, Ann Arbor, Michigan 48109-0396

Abstract

In this study, we explored what effect inhibitors of the 26S proteasome have on cell cycle distribution and induction of apoptosis in human skin fibroblasts and colon cancer cells differing in their p53 status. We found that proteasome inhibition resulted in nuclear accumulation of p53. This was surprising because it is thought that the degradation of p53 is mediated by cytoplasmic 26S proteasomes. Nuclear accumulation of p53 was accompanied by the induction of both p21WAF1 mRNA and protein as well as a decrease in cells entering S phase. Interestingly, cells with compromised p53 function showed a marked increase in the proportion of cells in the G2-M phase of the cell cycle and an attenuated induction of apoptosis after proteasome inhibition. Taken together, our results suggest that proteasome inhibition results in nuclear accumulation of p53 and a p53-stimulated induction of both G1 arrest and apoptosis.




This article has been cited by other articles:


Home page
IOVSHome page
S. Bhattacharya, E. Chaum, D. A. Johnson, and L. R. Johnson
Age-Related Susceptibility to Apoptosis in Human Retinal Pigment Epithelial Cells Is Triggered by Disruption of p53-Mdm2 Association
, December 19, 2012; 53(13): 8350 - 8366.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. Huang, S.-R. Ho, K. Wang, B. C. Roessler, F. Zhang, Y. Hu, D. B. Bowe, J. E. Kudlow, and A. J. Paterson
Muscle-specific overexpression of NCOATGK, splice variant of O-GlcNAcase, induces skeletal muscle atrophy
Am J Physiol Cell Physiol, March 1, 2011; 300(3): C456 - C465.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Xu, L. Timares, C. Heilpern, Z. Weng, C. Li, H. Xu, J. G. Pressey, C. A. Elmets, L. Kopelovich, and M. Athar
Targeting Wild-Type and Mutant p53 with Small Molecule CP-31398 Blocks the Growth of Rhabdomyosarcoma by Inducing Reactive Oxygen Species-Dependent Apoptosis
Cancer Res., August 15, 2010; 70(16): 6566 - 6576.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
F. Zhang, A. J. Paterson, P. Huang, K. Wang, and J. E. Kudlow
Metabolic Control of Proteasome Function
Physiology, December 1, 2007; 22(6): 373 - 379.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Yu, M. Carroll, and A. Thomas-Tikhonenko
p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitors
Blood, June 1, 2007; 109(11): 4936 - 4943.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
N. Laurent, S. de Bouard, J.-S. Guillamo, C. Christov, R. Zini, H. Jouault, P. Andre, V. Lotteau, and M. Peschanski
Effects of the proteasome inhibitor ritonavir on glioma growth in vitro and in vivo
Mol. Cancer Ther., February 1, 2004; 3(2): 129 - 136.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. A. Williams and D. J. McConkey
The Proteasome Inhibitor Bortezomib Stabilizes a Novel Active Form of p53 in Human LNCaP-Pro5 Prostate Cancer Cells
Cancer Res., November 1, 2003; 63(21): 7338 - 7344.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
V. Atlashkin, V. Kreykenbohm, E.-L. Eskelinen, D. Wenzel, A. Fayyazi, and G. Fischer von Mollard
Deletion of the SNARE vti1b in Mice Results in the Loss of a Single SNARE Partner, Syntaxin 8
Mol. Cell. Biol., August 1, 2003; 23(15): 5198 - 5207.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. Chen, L. Smith, Z. Wang, and J. B. Smith
Preservation of Caspase-3 Subunits from Degradation Contributes to Apoptosis Evoked by Lactacystin: Any Single Lysine or Lysine Pair of the Small Subunit Is Sufficient for Ubiquitination
Mol. Pharmacol., August 1, 2003; 64(2): 334 - 345.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
S. Yanamadala and M. Ljungman
Potential Role of MLH1 in the Induction of p53 and Apoptosis by Blocking Transcription on Damaged DNA Templates
Mol. Cancer Res., August 1, 2003; 1(10): 747 - 754.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
A. Chauchereau, L. Amazit, M. Quesne, A. Guiochon-Mantel, and E. Milgrom
Sumoylation of the Progesterone Receptor and of the Steroid Receptor Coactivator SRC-1
J. Biol. Chem., April 4, 2003; 278(14): 12335 - 12343.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Leverkus, M. R. Sprick, T. Wachter, T. Mengling, B. Baumann, E. Serfling, E.-B. Brocker, M. Goebeler, M. Neumann, and H. Walczak
Proteasome Inhibition Results in TRAIL Sensitization of Primary Keratinocytes by Removing the Resistance-Mediating Block of Effector Caspase Maturation
Mol. Cell. Biol., February 1, 2003; 23(3): 777 - 790.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
J. S. Isaacs, S. Saito, and L. M. Neckers
Requirement for HDM2 Activity in the Rapid Degradation of p53 in Neuroblastoma
J. Biol. Chem., May 25, 2001; 276(21): 18497 - 18506.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. A. Klibanov, H. M. O'Hagan, and M. Ljungman
Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress
J. Cell Sci., May 15, 2001; 114(10): 1867 - 1873.
[Abstract] [PDF]


Home page
J Biol ChemHome page
J. S. Isaacs, S. Saito, and L. M. Neckers
Requirement for HDM2 Activity in the Rapid Degradation of p53 in Neuroblastoma
J. Biol. Chem., May 25, 2001; 276(21): 18497 - 18506.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2000 by the American Association of Cancer Research.